Definition/General

Introduction:
-Colloid nodule (adenomatoid nodule) is the most common benign thyroid lesion encountered on FNAC
-It represents hyperplastic areas within multinodular goiter and is characterized by abundant thick colloid with benign follicular epithelial cells
-Falls under Bethesda Category II (Benign) and accounts for 60-70% of thyroid FNAC diagnoses.
Origin:
-Develops from thyroid follicular epithelium as part of multinodular goiter
-Result of alternating stimulation and regression cycles
-TSH stimulation leads to follicular hyperplasia followed by involution with colloid accumulation.
Classification:
-Bethesda System for Reporting Thyroid Cytopathology classifies as Category II (Benign)
-Subtypes include macrofollicular variant (large follicles with abundant colloid) and microfollicular variant (smaller follicles with less colloid).
Epidemiology:
-Most common thyroid lesion globally
-Prevalence increases with age, especially >40 years
-Female predominance (4:1)
-More common in iodine-deficient areas
-Indian population shows high prevalence due to endemic goiter.

Clinical Features

Presentation:
-Usually asymptomatic thyroid nodules
-Part of multinodular goiter in majority of cases
-Slow-growing masses
-May present as solitary nodule but often multiple nodules on imaging.
Symptoms:
-Mostly asymptomatic
-Large nodules may cause compressive symptoms (dysphagia, dyspnea)
-Cosmetic concerns in visible nodules
-Thyroid function usually normal (euthyroid state).
Risk Factors:
-Iodine deficiency (most important)
-Advanced age >40 years
-Female gender
-Genetic predisposition
-Previous radiation exposure
-Dietary goitrogens.
Screening:
-Thyroid ultrasound shows well-defined nodules with mixed echogenicity
-Coarse calcifications may be present
-Normal thyroid function tests in most cases
-Elevated TSH in some cases of multinodular goiter.

Master Colloid Nodule Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Well-demarcated nodule with smooth surface
-Cut surface shows glistening appearance due to colloid
-Color ranges from yellow to brown
-Consistency varies from soft to firm.
Characteristics:
-Encapsulated or well-circumscribed nodule
-Size varies from few millimeters to several centimeters
-Colloid-filled cystic spaces visible
-Hemorrhage and calcification possible in large nodules.
Size Location:
-Size ranges 0.5-8 cm (average 2-3 cm)
-Can occur anywhere in thyroid gland
-Multiple nodules common
-Cystic degeneration in larger nodules.
Multifocality:
-Multifocal disease common (multinodular goiter)
-Bilateral involvement frequent
-Various stages of nodular development
-Heterogeneous appearance on imaging.

Microscopic Description

Histological Features:
-Large and small follicles lined by benign follicular epithelium
-Abundant intrafollicular colloid with peripheral vacuolization
-Flat to low cuboidal epithelium
-Minimal inflammatory infiltrate.
Cellular Characteristics:
-Benign follicular cells with uniform nuclei and distinct nucleoli
-Cells arranged in flat sheets and honeycomb pattern
-Nuclear-cytoplasmic ratio low
-Chromatin finely granular.
Architectural Patterns:
-Macrofollicular architecture predominant
-Follicles of varying sizes
-Colloid shows peripheral scalloping
-Papillary projections absent
-No capsular or vascular invasion.
Grading Criteria:
-No grading system applicable as benign lesion
-Assessment based on cellular atypia (absent), mitotic activity (minimal), and architectural features (preserved follicular pattern).

Immunohistochemistry

Positive Markers:
-Thyroglobulin positive (diagnostic)
-TTF-1 positive
-CK19 may be focally positive
-PAX-8 positive
-Thyroid peroxidase (TPO) positive.
Negative Markers:
-Calcitonin negative (excludes medullary carcinoma)
-CK20 negative
-CEA negative
-Chromogranin negative
-Synaptophysin negative.
Diagnostic Utility:
-Thyroglobulin confirms thyroid follicular origin
-TTF-1 supports thyroid lineage
-Normal expression pattern excludes malignancy
-CK19 limited focal staining unlike papillary carcinoma.
Molecular Subtypes:
-No specific molecular subtypes
-Normal thyroid follicular cell immunophenotype
-Absence of molecular alterations associated with malignancy
-BRAF mutation negative.

Molecular/Genetic

Genetic Mutations:
-Usually no significant mutations
-Polyclonal proliferation unlike neoplasms
-Rare RAS mutations in some adenomatoid nodules
-BRAF mutations absent.
Molecular Markers:
-Normal p53 expression
-Low Ki-67 proliferation index (<2%)
-Normal cyclin expression
-Absence of molecular markers of malignancy.
Prognostic Significance:
-Excellent prognosis with no malignant potential
-Risk of malignant transformation extremely low (<1%)
-Long-term growth monitoring sufficient.
Therapeutic Targets:
-No specific therapy required for benign nodules
-TSH suppression therapy controversial
-Radioiodine therapy for toxic multinodular goiter
-Surgery only for compressive symptoms.

Differential Diagnosis

Similar Entities:
-Follicular adenoma
-Follicular carcinoma
-Papillary thyroid carcinoma (follicular variant)
-Hashimoto thyroiditis
-Graves disease
-Parathyroid adenoma.
Distinguishing Features:
-Follicular adenoma: encapsulated neoplasm, microfollicular pattern
-Follicular carcinoma: nuclear atypia, capsular invasion
-Papillary carcinoma: nuclear features, CK19 diffuse positivity
-Hashimoto: lymphocytic infiltrate, Hurthle cells.
Diagnostic Challenges:
-Distinction from follicular neoplasm when microfollicular areas present
-Cystic degeneration may obscure morphology
-Hemorrhage may cause reactive changes
-Sampling adequacy important.
Rare Variants:
-Colloid nodule with papillary hyperplasia
-Nodular goiter with Hurthle cell change
-Colloid nodule with oxyphilic metaplasia
-Nodular goiter with squamous metaplasia.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Site and Procedure

Site: Thyroid [right/left/isthmus], Procedure: Fine needle aspiration cytology

Adequacy

Adequate for evaluation (>6 groups of follicular cells, each with >10 cells)

Background

Abundant thick, viscous colloid with peripheral scalloping

Cellularity

Low to moderate cellularity relative to colloid

Cellular Pattern

Flat sheets of follicular epithelial cells in honeycomb pattern

Cellular Features

Uniform follicular cells with round nuclei and distinct nucleoli

Nuclear Features

Benign nuclear morphology, no nuclear atypia or pseudo-inclusions

Special Features

No Hurthle cells, lymphocytes, or atypical features

Cytological Diagnosis

Benign follicular nodule (colloid nodule) - Bethesda Category II

Recommendation

Clinical correlation and ultrasound follow-up as clinically indicated